IDEAYA Biosciences (IDYA) Tops Q3 EPS by 133c

IDEAYA Biosciences (NASDAQ: IDYA) reported Q3 EPS of $1.33. Revenue for the quarter came in at $207.83 million.

For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Edge Total Intelligence Provides Business Update: Preliminary Second Quarter and First-Half Revenue, Special AGM Matters, and Strategic Growth
• Alphabet (GOOGL) Reiterated at Market Outperform by Citizens on YouTube's Scale, Distribution